(Q24296795)

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05326.X

Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05326.X

Fatty acid binding to human serum albumin: new insights from crystallographic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05326.X

Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05326.X

Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05326.X

Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05326.X

Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05326.X

Atomic structure and chemistry of human serum albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05326.X

Locations of the three primary binding sites for long-chain fatty acids on bovine serum albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05326.X

Interactions of long-chain fatty acids and albumin: determination of free fatty acid levels using the fluorescent probe ADIFAB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05326.X

Characterization of site I on human serum albumin: concept about the structure of a drug binding site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05326.X

A point mutation in the human serum albumin gene results in familial dysalbuminaemic hyperthyroxinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05326.X

Studies on the nature of iodothyronine binding in familial dysalbuminemic hyperthyroxinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05326.X

Resolution and binding site determination of D,L-thyronine by high-performance liquid chromatography using immobilized albumin as chiral stationary phase. Determination of the optical purity of thyroxine in tablets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05326.X

Familial dysalbuminemic byperthyroxinemia may result in altered warfarin pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05326.X

7 January 2021

Chiral separation mechanisms in protein-based HPLC columns. 2. Kinetic studies of (R)- and (S)-warfarin binding to immobilized human serum albumin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05326.X

7 January 2021

Mutagenesis studies of thyroxine binding to human serum albumin define an important structural characteristic of subdomain 2A

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05326.X

7 January 2021

Mutations in a specific human serum albumin thyroxine binding site define the structural basis of familial dysalbuminemic hyperthyroxinemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05326.X

7 January 2021

Successful Targeting to Rat Hepatic Stellate Cells Using Albumin Modified with Cyclic Peptides That Recognize the Collagen Type VI Receptor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05326.X

7 January 2021

Influence of fatty acids on the binding of warfarin and phenprocoumon to human serum albumin with relation to anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05326.X

7 January 2021

Reduced warfarin binding of albumin variants

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2002.TB05326.X

7 January 2021